carmustine and novobiocin

carmustine has been researched along with novobiocin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrows, LR; Ireland, CM; Kokoshka, JM1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Cathcart, KN; Eder, JP; Frei, E; Holden, SA; Schnipper, LE; Teicher, BA1
Cathcart, KN; Eder, JP; Holden, SA; Schnipper, LE; Teicher, BA1
Ali-Osman, F; Berger, MS; Livingston, RB; Rajagopal, S; Spence, A1

Other Studies

7 other study(ies) available for carmustine and novobiocin

ArticleYear
Cell-based screen for identification of inhibitors of tubulin polymerization.
    Journal of natural products, 1996, Volume: 59, Issue:12

    Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured

1996
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
    Cancer research, 1989, Feb-01, Volume: 49, Issue:3

    Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Survival; Cyclophosphamide; Fibrosarcoma; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Novobiocin; Organoplatinum Compounds

1989
Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model.
    The Journal of clinical investigation, 1987, Volume: 79, Issue:5

    Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Survival; Cisplatin; Cricetinae; Cricetulus; DNA; Drug Synergism; Female; Fibrosarcoma; Leukemia L1210; Mice; Novobiocin; Ovary; Topoisomerase II Inhibitors

1987
Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
    Cancer research, 1993, Dec-01, Volume: 53, Issue:23

    Topics: Carmustine; Cell Survival; Cisplatin; DNA; DNA Repair; Glioblastoma; Humans; Novobiocin; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1993